chrisvoncsefalvay/vaers-outcomes huggingface dataset:
little arm pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (little arm pain) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history.).    On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (little arm pain). At the time of the report, PAIN IN EXTREMITY (little arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided No treatment information provided
On approximately 10/01/2022, I had labs done and they diagnosed me with Hyperthyroidism. It was during a regular check. I had to stop what I was taking and continue monitoring labs. Then I had to take another medication. I am ok now. I have to have surgery now on March 28, 2023.
Patient reports that left was ok for 2 days after Shingrix vaccine and then she subsequently developed slowly worsening shoulder pain and loss of ROM. No trauma that she can recall at the time. Has continued lifting with the arm when needed. On exam she is tender over the supraspinatus tendon, biceps tendon. Increased tone in the left neck. Left shoulder abduction limited to 90 degrees due to pain, 140 degrees with flexion. Pain with empty can test, positive lift off test, positive speed's test, positive Hawkins-Kennedy sign. Based on story, this is concerning for initial rotator cuff injury due to vaccine injection site.
Was notified two days after the vaccine was already given that It was the wrong dose. Patient received a hep A vaccine on 10-12-20 for her 12 month check up. She was suppose to receive. 5 ml but instead was given 1ml. I was called today at 10-14-20 around 5 pm to be notified that she was given the wrong dose.
Case number PHEH2015US000675, is an initial spontaneous report from a pharmacist received on 05 Jan 2015. This report refers to a 59-year-old female patient. Historical conditions were not reported. No concomitant medication was reported. The patient was vaccinated with FLUVIRIN (batch number: 145205) intramuscularly at a dose of 0.5 ml on 08 Oct 2014. The pharmacist reported that FLUVIRIN reached below 36 F for 3.5 non-consecutive days and 33.1 F for less than 12 hours. The pharmacist does not believe that the vaccine was frozen instead thinks it was thermometer malfunction. No adverse event was reported following the maladministration (incorrect storage of drug). No further information was provided.
Initial unsolicited report received from a health care professional via other company on 21 JANUARY 2015. An unknown patient (age and gender not reported), whose medical history and concomitant medications were not reported had received a dose of INFLUENZA (batch number, route and site of administration not reported) on an unspecified date. It was reported that on an unspecified date after the vaccination the patient had experienced difficulty in breathing and felt warm. Laboratory investigations and corrective treatments were not reported. At the time of this report the patient outcome was recovered on an unspecified date. Documents held by sender: none.
On April 8th at 3:30 a.m., I woke up nauseated, sweating and with a huge headache.  I was very cold throughout the day and couldn't warm up.  Very similar to what happened about  3 weeks ago after my first dose.  This lasted about 24 hours, but the headache lingered throughout the second day.
He also got shingles after his Moderna vaccine.; This spontaneous case was reported by a health care professional and describes the occurrence of HERPES ZOSTER (He also got shingles after his Moderna vaccine.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, the patient experienced HERPES ZOSTER (He also got shingles after his Moderna vaccine.). At the time of the report, HERPES ZOSTER (He also got shingles after his Moderna vaccine.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications was reported.  No treatment details were provided. patient priest got shingles after his Moderna Covid-19 vaccine on 17-may-2021.   This case was linked to US-MODERNATX, INC.-MOD-2021-137922, US-MODERNATX, INC.-MOD-2021-138184 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-137922:Same reporter US-MODERNATX, INC.-MOD-2021-138184:Same reporter, different patient
Systemic: Allergic: Difficulty Breathing-Mild, Systemic: Allergic: Difficulty Swallowing, Throat Tightness-Mild, Systemic: Allergic: Swelling of Face / Eyes / Mouth / Tongue-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild
This is a spontaneous report from a contactable pharmacist via a Pfizer sales representative. A 65-year-old female patient of unspecified ethnicity received PREVNAR 13, via an unspecified route of administration in the arm, on an unspecified date, at single dose, for immunisation. The patient's medical history was not reported. Concomitant medication included influenza vaccine (unspecified trade name) in the other arm, at high dose, for immunisation. The vaccines were administered the same day. The patient experienced burning sensation at vaccination site (more severe than with influenza vaccine) on an unspecified date with outcome of unknown. The reporter assessed that the event was probably related to Prevnar 13.
Refusing to eat, refusing to nap, biting nipple when offered breast to nurse then refusing it, constant crying. Her crying was much more upset sounding than any usual crying or fussing she has at times. Also, this is a child who normally loves to nurse and never refuses it. Got her to go to sleep around 8:30, but kept waking after that. She has never acted like this with previous vaccines.
Client felt dizzy and light headed.  Client describes a warm sensation and reports feeling better after a few minutes.  Sp02 99%, BP 108/68
The patient received his vaccination 2-26-22, 2 days later on 2-28-22, when he returned to work he noticed that his left arm (the arm that received the vaccination) felt like it had pins and needles and numbness in his shoulder area. He also can not hold his arm up for more than a minute at a time before he has to put it down due to the pain. He has limited range of motion in his left shoulder now. He has been experiencing these symptoms every day since 2-28-22. He tries to take OTC pain relievers, such as Tylenol, to help manage the pain but he says that nothing helps.  He haven't seen a provider yet, but has an appointment today (11-22-22) to see a provider for the condition.
Covid like symptoms as severe as the covid symptoms experienced when I had covid. Heart palpitations that come and go.
A family member called & states child (on Sunday 09/27/09) developed a knot on breast, became short of breath & was admitted to the hospital. Dr states this was caused by the immunizations given on 09/25/09."  10/6/09 MR received for DOS 9/27-28/09 with DX: Hypoxia, Fever. Pt presented with cough, fever, SOB, as well as injection site erythema, tenderness and induration on the left arm. Cyanotic on admission, O2 sat 80%. Assessed as FUO, most likely 2' to immunizations. Tx abx and IVF and observed o/n.
Injection site pain; Tiredness; Headache; Muscle pain; Severe chills; Joint pain; Severe fever; Very severe nausea; Vomiting; Feeling unwell; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0176) via an unspecified route of administration in the arm left on 04May2021 at 14:15 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no known allergies to medications, food or other products. Concomitant medications included dexamethasone, neomycin sulfate, polymyxin b sulfate (MAXITROL) eyedrop from an unknown date for unspecified indication. The patient previously received first dose BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, lot number: Ew0151) via an unspecified route of administration in the left arm on 06Apr2021 at 14:15 (at the age of 32-years-old) as a single dose for COVID -19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 05May2021 at 09:00, the patient experienced injection site pain, tiredness, headache, muscle pain, severe chills, joint pain, severe fever, very severe nausea, vomiting, feeling unwell. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care.  No therapeutic measures were taken as a result of the reported events. The clinical outcomes of injection site pain, tiredness, headache, muscle pain, severe chills, joint pain, severe fever, very severe nausea, vomiting, feeling unwell were recovering.    No follow-up attempts are needed. No further information is expected.
took the Pfizer vaccine before I know that I have COVID; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; Batch/Lot number and Expiration date were not reported), via an unspecified route of administration on an unspecified date as 1st dose, single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced took the Pfizer vaccine before I know that I have COVID on an unspecified date. It was reported that the patient took the vaccine and stated that after a few days, the PCR results showed that he has COVID and that was '5 days' ago (not clarified). The patient was asking if when can he do the second shot and if he needed to start from the first shot over or just continue with the second shot. The patient also stated that he took the vaccination because when he did the first rapid test, it was negative but when the PCR came up, it was positive. So, he stated that he took it at the same time while he has COVID. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
t104.3 R as seen in ER 10 hrs p/immun; parents were directed to ER; parents report dx ear infection;
Baseball size swelling, heat, and itching in injection area afternoon of injection. Following morning: low grade fever (up to 100), severe headache, flu like symptoms and extreme fatigue for 24 hours. No treatment other than Tylenol and anti-itching cream
Patient called to report that she was experiencing widespread itching after receiving the vaccine. She has never had a reaction to a flu shot in the past. Pt was told to take diphenhydramine and contact MD if symptoms worsen.
This spontaneous report was received from a consumer (the patient's mother) and refers to a currently 27-year-old female patient. No information about the patient's pertinent medical history, concomitant medications, drug reactions or allergies was reported. On unspecified dates in 2007, at the age of 16, the patient was vaccinated with the series (number of doses was not specified) of GARDASIL, intramuscular injections (dose, frequency, strength, lot number or expiration dates were not reported), for prevention of Human Papilloma Virus (HPV). On an unknown date (reported as "recently"), the patient had a pap smear and was diagnosed with a high risk HPV types 16 and 18. The patient sought medical attention by contacting an unspecified physician. The outcome of high risk HPV (types 16 and 18) was reported as not recovered. The causality assessment between the event and GARDASIL was not provided. Additional information is not expected as the reporter did not wish to contact the patient's physician.
Extreme fatigue, fewer periods and shorter periods, insomnia, joint paint, joint swelling, joint abscesses, facial fat loss, muscle soreness. Extreme swelling at the site of bruises, bug bites, and longer recovery times. Receding hairline yet more facial hair.
fatigue; This is a spontaneous report from a Pfizer- sponsored program Support Program. A contactable  reporter reported for a female patient that: A 59-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for COVID-19 immunization. Patient also took palbociclib (IBRANCE), (Batch/Lot number was not reported) via an unspecified route of administration from an unspecified date to an unspecified date, at 125 mg for Malignant neoplasm of unspecified site of unspecified female breast. The patient medical history and concomitant medications were not reported. The patient experienced fatigue on an unspecified date. Patient further stated that during patient side effect follow up call, patient reported an improvement in her previously reported side effects. Symptoms included: Nausea, fatigue, and abnormal white count. She reports an improvement with fatigue after dietary changes and a medication prescribed by her doctor. She noted that she did feel fatigue after her second dose of COVID-19 vaccine, but otherwise with the medication she noted improvement in her fatigue. Finally, her white count on follow up labs was appropriate to continue therapy. The patient underwent lab tests and procedures which included white blood cell count: abnormal on an unspecified date. Patient received treatment for the events. Outcome of event was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
On 02/12/2023, I called the doctor for lightheadedness and dizziness and visual issues, motion sensitivity. I had ear fullness. I had a headache. I laid on the floor until the symptoms subsided. I took prednisone.
Patient reports symptoms started about 4 hours after vaccine. States he feels like he has the flu, bones/joint aches (not limited to shoulder), headache, vomiting, congestion, feeling very tired. Will monitor symptoms and provide supportive care. Patient instructed to call if symptoms worsen or if he starts to develop s/sx of allergic reaction.
Fever, chills, headache, & joint pain.  Lasted approximately 8-12 hours
Patient received AFLURIA & PNEUMOVAX on 1/25/2013. Patient came down w/ hi fever that night. The injection site was swollen. Patient (R) arm was tattooed all over. I could only IM on (L) arm.
Terrible itching started on left side of torso  Rash  and hives on my back that are still present 5 days after shot
Acute onset motor tic. General sx's - entire body. Sx's resolved after 3 months.
Nausea 10' after vaccination  Brain fog and feeling like traveling in a ship when moving the head Some days intense symptoms others mild but always present Better feeling evenings No symptoms during sleep
vaccination received 4/20/22 syncopal event 4/23/22 followed by another on 4/25/22, which prompted his mother to bring him to the ED All labs were WNL, feeling better at clinic today
Kinrix was given, patient was supposed to get the Dtap component only and was given the combination vaccine in error, consulted with provider. Patient was advised she just got an additional dose of IPV, Dtap was correct.
Debilitating muscle fatigue, unable to get up or stand on own, severe chills, fatigue and body aches, sharp pain in neck lymph glands  (new from last vaccine), neuropathy in hands and feet (new since last vaccine), nausea.
Moderna Covid-19 Vaccine EUA  After about 7 days getting vaccine, rash started from the spot where the vaccine was given, then spread to whole body, red, and very itchy.  I've been taking Benadryl to help sleep.  It has been 4 days and haven't recovered yet.
This report describes a 45 y.o. female who did not respond to the Hep B vaccine recombinant (Engerix-B) immunization series. The subject's medical history included diabetes mellitus and hypertension. Concurrent medications included amlodipine besylate/benazepril hydrochloride (Lotrel) and glipizide (Glucotrol XL). She received no concurrent vaccines. The subject experienced no adverse events following previous immunizations. The subject received Engerix-B on 11/27/01, 12/28/01, and 5/23/02. Lots of vaccine administered were ENG5239A4 (1st two injections) and ENG5299A4 (3rd injection). A titer (NOS) measured on 7/23/02, 2 months after the 3rd injection, showed a value of "0" (10 being considered a protective level). The reporting nurse considered this non-response to be possibly related to Engerix-B administration.
wrong Diluent used . was diluted with bacteriostatic sodium chloride . not sodium Chloride supplied with vaccine
The vial was first punctured on 14-Nov-2022 03:00 PM and administered on 15-Nov-2022 08:45 AM; No adverse event; Moderna booster dose given to a patient but it was expired / Dose administered more than 12 hours post puncture; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna booster dose given to a patient but it was expired / Dose administered more than 12 hours post puncture), PRODUCT STORAGE ERROR (The vial was first punctured on 14-Nov-2022 03:00 PM and administered on 15-Nov-2022 08:45 AM) and NO ADVERSE EVENT (No adverse event) in a 55-year-old patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 030G22B) for COVID-19 prophylaxis.     No Medical History information was reported.    On 15-Nov-2022 at 8:45 AM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 15-Nov-2022 at 8:45 AM,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna booster dose given to a patient but it was expired / Dose administered more than 12 hours post puncture). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was first punctured on 14-Nov-2022 03:00 PM and administered on 15-Nov-2022 08:45 AM) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna booster dose given to a patient but it was expired / Dose administered more than 12 hours post puncture), PRODUCT STORAGE ERROR (The vial was first punctured on 14-Nov-2022 03:00 PM and administered on 15-Nov-2022 08:45 AM) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (Moderna booster dose given to a patient but it was expired / Dose administered more than 12 hours post puncture) and PRODUCT STORAGE ERROR (The vial was first punctured on 14-Nov-2022 03:00 PM and administered on 15-Nov-2022 08:45 AM).    Concomitant medication was not provided.  It was reported that the vial was initially stored in refrigerator on 10-Nov-2022 and administered on 15-Nov-2022 08:45 AM. Only one vial underwent product storage error and size of the vial was 2.5ml. Vial was then stored in the room temperature. The vial did not undergo any temperature excursion. Total amount of time the vial  exposed to room temperature range (8° to 25°C= 46° to 77°F) was 17 hours.  Treatment information was not provided.
Client c/o feeling shaky and denies any other symptoms.  Client seen by EMT and all vitals are within normal limits. Client then verbalized that she had been nervous about receiving vaccine.  Client cleared by EMT to go home.
presents for evaluation of persistent mid-sternal chest pain since 0800 this morning. Pt states over the past few days she has felt generally weak. Today while she was walking, she developed mid-sternal CP. She called the Nurse line who recommended evaluation in the ED. Denies talking aspirin or any other medications today. Denies associated SOB.
Information has been received from a male who was vaccinated with a dose of hep B virus vaccine rHBsAg (yeast). The pt reported that he subsequently developed a facial rash. It was unk if medical attention was sought. Subsequently, the pt's rash resolved. No further information is available.
This spontaneous report as received from a nurse (registered nurse, RN) refers to an unspecified number of unspecified patients of unknown age and gender. Medical history and drug reactions or allergies were not specified. On unspecified dates, improperly stored doses of ROTATEQ (strength, dose number, dose frequency, lot number and indication were not reported) were administered to an unspecified number of unspecified patients. No adverse effects were reported. Concomitant medications were not specified. This is one of several reports received from the same reporter (linked to MARRS # 1406USA000382, 1406USA000550, 1406USA000551, 1406USA00552). Additional information has been requested.
arm pain/has gotten bad again; can't lift her left arm; vaccine that is irritating her muscle; believes that the vaccine was either injected incorrectly; This case was reported by a consumer via call center representative and described the occurrence of pain in arm in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 28th October 2020, the patient received the 1st dose of Shingrix. On 28th October 2020, less than a day after receiving Shingrix, the patient experienced pain in arm, mobility decreased, injection site irritation and vaccine administered at inappropriate site. On an unknown date, the outcome of the pain in arm and mobility decreased were not recovered/not resolved and the outcome of the injection site irritation and vaccine administered at inappropriate site were unknown.   It was unknown if the reporter considered the pain in arm, mobility decreased and injection site irritation to be related to Shingrix.  Additional details were provided as follows:  After receiving 1st dose of Shingrix, the patient experienced arm pain and she still could not lift her left arm. The patient was also left-handed. The patient reported that the pain had improved a little after doing PT, however, it had gotten bad again even though she was still doing PT at home. The reporter believed that ,the vaccine was either injected incorrectly or there was something in the vaccine that was irritating her muscle, which led to vaccine administered to inappropriate site. The reporter consent to follow up.
"51yo female w/second COVID vaccine- on Thursday 04Feb21- now w/HA, N/V- beginning yesterday. Yesterday with emesis x 3, one episode today. Drinking/eating- apple juice, water, saltine crackers. No fever. +mild cough. Pfizer vaccine. Would like work excuse for yesterday and today."